Home > Healthcare > Medical Services > Lab Services > Central Lab Market

Central Lab Market Size

  • Report ID: GMI10831
  • Published Date: Aug 2024
  • Report Format: PDF

Central Lab Market Size

Central Lab Market size was valued at around USD 3.1 billion in 2023 and is expected to reach around USD 5.1 billion by 2032 at a CAGR of 5.8% during the forecast period. The growing emphasis on outsourcing of testing services coupled with extensive growth in research and development investments are driving the market growth.

 

Outsourcing testing services is increasingly driving the growth of the central lab market, as organizations seek cost efficiency, high-quality outcomes, and specialized testing capabilities. The U.S. Food and Drug Administration (FDA) reported a 25% increase in clinical trials utilizing outsourced central laboratory services in 2022 compared to 2019, highlighting the growing reliance on these specialized labs for critical testing. This trend allows organizations to focus on their core activities while central labs provide precise and efficient testing, thereby accelerating market expansion.
 

A central lab is a dedicated facility or group of laboratories that provides comprehensive laboratory testing services for clinical trials, pharmaceutical research, and various diagnostic purposes. These labs are equipped with advanced technologies and staffed by skilled professionals to conduct a wide range of tests and analyses on biological samples, including blood, urine, tissue, and other specimens.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global central lab industry was valued at USD 3.1 billion in 2023 and is anticipated to register 5.1% CAGR between 2024 and 2032 due to growing emphasis on outsourcing of testing services and extensive growth in R&D investments.

The biomarker services segment in the market accounted for USD 934.5 million in 2023, driven by the rise of precision medicine and the pharmaceutical industry's increasing reliance on biomarkers for drug development.

North America central lab market size accounted for USD 1.1 billion in 2023 due to increasing focus on personalized medicine and rising incidence of chronic diseases.

A.P. Moller Holding A/S, ACM Global Laboratories, BioAgilytix Labs, Cerba Research, Cirion Biopharma Research Inc., Covance Inc., Eurofins Scientific, Frontage Laboratories, ICON Central Laboratories, and LabConnect, among others.

Central Lab Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 121
  • Countries covered: 23
  • Pages: 110
 Download Free Sample